Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 11Terminated 3Withdrawn 2Unknown 2Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1

Conditions

Lymphoma 3Sarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma, Large B-Cell, Diffuse 2Recurrence 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Hodgkin Disease 1Disease Progression 1

Interventions

Topotecan 2Ifosfamide 2Etoposide 2trioctyl phosphine oxide 1indolepropanol phosphate 1imetelstat 1Vincristine 1Transplantation 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Pentetic Acid 1Minocycline 1Melphalan 1Heparin 1Glutamine 1GRN163L peptide 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1Busulfan 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Neuroectodermal Tumors, Primitive, Peripheral × Ifosfamide × Clear all
NCT01795430 2015-01-09

Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma

City of Hope Medical Center

Phase NA Withdrawn

Neuroectodermal Tumors, Primitive, Peripheral

NCT00334867 2013-06-28

Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma

Children's Oncology Group

Phase 3 Withdrawn
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡